We conducted a randomized, double-blind, parallel-group study to However, the increase in the number and size of vessels can assess the effect of 6 weeks treatment with low-dose (100 g twice contribute to thickening of the airway wall, which in turn a day) or high-dose (500 g twice a day) inhaled fluticasone propiomay lead to critical narrowing of bronchial lumen, when nate (FP) on the vascular component of airway remodeling in 30 bronchial smooth muscle contraction occurs (11).
Inhaled corticosteroids are the most effective antiasthma on the inflammatory cells and the basement membrane thickness, drugs because they act on airway cellular inflammation (12) and we compared findings from bronchial biopsies taken in patients and may reduce the thickness of the basement membrane with asthma with those in eight control subjects. Bronchial respon- (13) . However, to date, studies on the effect of inhaled cortisiveness to methacholine and asthma symptom score were meacosteroids on microvascular airway remodeling in patients sured before and after treatments. Eight patients in the low-dose with asthma are scant. In a cross-sectional study, Orsida and relationship with vascular remodeling.
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The present study was specifically addressed to assess in biopsy a double-blind manner, the effect of short-term treatment with high-dose (500 g twice a day) and low-dose (100 g The remodeling of airway wall is a distinctive feature of twice a day) inhaled fluticasone propionate (FP) on the vascuasthma, characterized by hypertrophy and hyperplasia of airlar component of airway remodeling in patients with asthma. way smooth muscle (1), increase in mucous glands (2), thickIn addition, we studied the effect of high-and low-dose FP ening of the reticular basement membrane (3), and qualitaon the inflammatory cells and the basement membrane thicktive and quantitative changes of airway blood vessels. Early ness as well as on bronchial responsiveness and symptoms. studies on the pathology of asthma showed edematous bronFor comparison purposes we also examined bronchial biopchial mucosa with dilated and congested blood vessels in sies obtained from healthy volunteers. Lastly, we evaluated patients with fatal disease (4, 5) . More recent in vivo quantitathe relationship between inflammatory cells and number of tive studies found an increase in total number of vessels and vessels and percentage of vascular area. in vascular area in patients with asthma when compared with control subjects (6, 7) .
METHODS

Mediators involved in asthmatic inflammation, such as
Study Design
histamine (8) and bradykinin (9) can induce vasodilatation, as well as some cytokines present in the airways could determine
We conducted a double-blind, randomized, parallel-group study. Paformation of new vessels (10). The functional significance of tients received FP at a dose of 500 g twice daily or 100 g twice daily via a metered dose inhaler with a spacer device. Treatments were vascular changes in airway wall in asthma is not yet well known. administrated for 6 weeks, and patients attended the laboratory on five different days.
On Day 1, participants completed a clinical questionnaire, received a daily diary card, and underwent spirometry (16). On Day 2, after 3 (Received in original form July 17, 2002 ; accepted in final form November 18, 2002) weeks, diary cards were revised, the degree of asthma severity scored, Supported by a grant from GSK, Italy.
and patients performed spirometry. On the same occasion, patients underwent methacholine challenge (17) and the provocative concentra- . Three days later characteristics evaluated tissue sections using an image analysis system (Day 5), patients underwent a second bronchoscopy. Healthy volunteers (Leica Q500C; Leica Cambridge Ltd., Cambridge, UK). An average underwent the same bronchoscopy procedures on a single occasion.
of eight high power fields was examined for each subject included in Subjects the study. The mean coefficient of variation for repeated measurements was 9% for number of vessels, 11% for vascular area, 5% for mast Thirty nonsmoking patients with mild to moderate asthma were recells, 7% for eosinophils, and 11% for basement membrane thickness. cruited from the outpatient clinic of the Department of Clinical Sciences of the Parma University. All had a well-documented history of asthma Statistical Analysis (18), and baseline FEV 1 had to be 70% or more of predicted. All
Values are presented as mean Ϯ SD. The Mann-Whitney and 2 tests patients were free from asthma attacks in the previous 2 months and were used for comparison between patients with asthma and control controlled their symptoms with inhaled salbutamol only. They did not receive corticosteroids during the 6 months before the study and were subjects, when appropriate. Changes in functional data and morphologic free from respiratory infections in the 4 weeks preceding the study. data before and after treatment were calculated using the Wilcoxon The degree of asthma severity was assessed according to an asthma matched pairs test. Relationships were estimated by the Spearman's severity score (3). Atopy was assessed by skin prick tests with a battery rank correlation coefficient (r s ). A p value less than or equal to 0.05 of 10 common inhalant allergens. Eight healthy volunteers were enwas taken as significant. rolled as the control group. The study was approved by the University of Parma ethical committee, and subjects gave written informed consent.
RESULTS
Biopsy Processing
In patients with asthma (six females, age range 18-56 years), baseline FEV 1 values ranged from 70 to 148% and the PD 20 M Mucosal biopsies were immediately transferred into ice-cold acetone containing the protease inhibitor iodoacetamide (20 mM) and phenylvalues ranged from 0.056 to 14.26 mol. According to the asthma methylsulfonylfluoride (2 mM) for fixation; then they were stored at severity score, patients with asthma had mild persistent to mod-Ϫ20Њ C for 24 hours and processed into the water-soluble resin, glycolerately severe asthma (score range 3-11, median value 6). In methacrylate (Polysciences, Northampton, UK), for embedding (19).
addition, the duration of disease ranged from 1 to 27 years. In were not different from those found in healthy volunteers. This controlled study provides the first evidence that short-term ness of basement membrane, the number of vessels and the treatment with high-dose FP significantly reduce the vascular vascular area, measured after treatment with a high FP dose, component of airway remodeling in patients with mild to moderate asthma. This effect of high-dose FP was also observed on and the remodeling of the existing ones is unknown. Mediators and inflammatory cells can be involved in different ways. Among endothelial cell-specific growth factors, the vascular endothelial growth factor, whose expression is increased in the airways of subjects with asthma and is correlated with vascularity (23), has shown potent and clinically relevant effects on the microvasculature (24). Mast cells can also play a role in inducing the neovascularization process through the release of proangiogenic factors. Histamine, the major preformed mast cell mediator, stimulates new vessel growth by acting through both H 1 and H 2 receptors (25), and heparin, the main glycosaminoglycan constituent of mast cells granules, possess a proangiogenic activity (26). Our study, by providing evidence that mast cells are positively related to the number of vessels in patients with asthma, supports these observations. Moreover, mast cells produce and secrete vascular endothelial growth factor (27), which has been shown to stimulate mast cell migration at sites of angiogenesis (28) . However, it must be taken in account that vascular endothelial growth factor may also cause increased vascular permeability, vessel leak, edema, and tissue swelling, thereby reducing the density of vessels (29). Inhaled corticosteroids are able to downregulate several airway inflammatory cytokines (30), to reduce cell infiltration of bronchial wall (12), and may reverse the basement membrane thickening (13). They may also have some in vitro antiangiogenic density. Indeed, in subjects with asthma and normal control subjects, inhaled FP can induce a vasoconstrictive action in the airway mucosa, with 880 g being the lowest effective dose (32) . In this study, we provided evidence that 6 weeks treatment with basement membrane thickness. Conversely, both high-and low-500 g FP twice a day is able to reduce the vascular component dose FP reduce the number of inflammatory cells in the bronchial of airway remodeling in patients with mild to moderate asthma. mucosa, the degree of bronchial responsiveness to methacholine, After treatment with high-dose FP, the total number of vessels and symptom score. In addition, the study shows that when and the vascular area in patients with asthma were similar to compared with healthy control subjects, airway vascularity was those in healthy control subjects. However, from this observation significantly increased in patients with asthma and was correlated we cannot infer that high-dose FP can completely reverse the with the number of mast cells.
airway wall vascularity to the values of control subjects. In fact, Blood vessels number and percentage of vascular area obgiven the small number of subjects who completed the study, served in patients with asthma in our study were similar to those the lack of difference observed may in part be due to this small reported by Salvato (7), but they were smaller (6, 14) or greater number and reduced power to detect a persistent difference. (21) than those reported by others. Differences in selection criteOur results are consistent with the previous findings by Hosria of patients or in methods and in sampling sites can explain hino and coworkers (15), who showed that 800 g beclomethathese different results. In addition, the vessel distribution could sone dipropionate reduced airway wall vascularity in patients be uneven in the bronchial wall specimens because edema or with asthma. Interestingly, the duration of our study protocol fixation of the tissue can induce scattering or clustering of the was shorter than that of Hoshino and coworkers (6 weeks versus vessels. However, our results are consistent with previous papers 6 months). This suggests that a short-term treatment with a more reporting an increased vascularity of the bronchial wall in papotent inhaled steroid, given at a high dose, can be enough to tients with asthma when compared with control subjects (6, 7, reduce the airway vascular remodeling in asthma. Orsida and 14, 15, 21). Taken together, these findings support the view that coworkers (14) showed an effect of inhaled steroids on airway angiogenesis and microvascular remodeling of the airway wall wall vascularity only more than 500 g of beclomethasone dican be one of the main aspects characterizing the chronic inpropionate. Moreover, another study by Orsida and coworkers flammatory changes in bronchial asthma (22). Whether the vas- (33) failed to demonstrate any effect of 3 months treatment with cular component of airway remodeling is clinically relevant is a dose of 100 g FP twice a day plus a background dose of not yet clear. In our study, bronchial vascularity was not related inhaled steroids (200-500 g/day of beclometasone or 200-400 to clinical and functional grading of disease in agreement with g/day of budesonide) on vascularity in patients with asthma. the results of Li and Wilson (6), who did not find any relationship
We believe that our study, although it does not establish the between clinical variables and vascularity in patients with mild lowest dose and duration of FP that may be required to treat asthma. However, other studies (7, 21) , which included patients airway remodeling, adds a new finding to this debate by showing with a wider range of severity of disease, showed that patients that short-term treatment with 500 g FP twice a day can reduce with severe asthma had more vessels than patients with mild to the airway vascular remodeling in patients with asthma. moderate asthma, suggesting a possible relation between vascuIn this study, we found an effect of high-dose FP not only lar remodeling of the airway wall and asthma severity.
on the vascular component of airway remodeling but also on another component, i.e., the basement membrane thickening. The mechanism responsible for the formation of new vessels in bronchial biopsy specimens from asthmatic and non-asthmatic subIn patients receiving 500 g FP twice a day, the basement mem- inflammatory and structural changes in asthma.
24. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature
